BioScale banks $25M to back protein analytics tech

Cambridge, MA-based BioScale, a life sciences toolmaker founded by a trio of MIT professors, has rounded up $25 million in venture funding, with Morningside Venture leading the way as a new investor. Existing investors New Science Ventures, WFD Ventures, F2 Ventures, and several individual investors also chipped in to the round, which will be used to fuel the development and commercialization of its protein analytics technology. "Morningside's participation, along with the strong support of our...